Table 1 Baseline characteristics of the study population.

From: Risk factors and transitional probability of clinical events in Korean CKD patients using the multistate model

 

Total (N = 1502)

Age, years

54 (45–63)

Male, n (%)

921 (61.3)

Body mass index, kg/m2

24.4 (22.3–26.4)*

Hemoglobin, g/dL

13 (11.6–14.5)

BUN, mg/dL

18 (14–25)

Creatinine, mg/dL

1.4 (1.0–2.0)

eGFRcreatinine, mL/min/1.73 m2

46.7 (30.5–70.8)

Sodium, mEq/L

141 (140–142)

Potassium, mEq/L

4.5 (4.2–4.9)

Calcium, mg/dL

9.5 (9.1–9.8)

Phosphorus, mg/dL

3.6 (3.2–4.0)

Uric acid, mg/dL

6.9 (5.6–8.1)

Parathyroid hormone, pg/dL

49.25 (33.6–75.1)

CRP, mg/dL

0.6 (0.2–1.6)

Fasting glucose, mg/dL

99 (92–111)

HbA1C, %

6.3 (5.6–7.4)

Total cholesterol, mg/dL

172 (147–198)

HDL-C, mg/dL

47 (39–59)

LDL-C, mg/dL

94 (74–115)

FGF-23, pg/mL

18.2 (1.3–31.9)

Spot urine protein-to-creatinine ratio, mg/mg

1.12 (0.01–16.75)

Systolic blood pressure, mmHg

126 (118–135)*

Diastolic blood pressure, mmHg

77 (70–84)

Comorbidities

 

  Hypertension, n (%)

1435 (95.5)

  Diabetes mellitus, n (%)

466 (31.0)

  Coronary artery disease, n (%)

94 (6.3)

  Chronic heart failure, n (%)

18 (1.2)

Smoking status, n (%)

 

  Current

240 (16.0)

  Former

471 (31.4)

  Never

791 (52.6)

CKD subtype, n (%)

 

  Diabetes mellitus

356 (23.7)

  Hypertension

287 (19.1)

  Glomerulonephritis

570 (38.0)

  Polycystic kidney disease

289 (19.2)

  1. *BUN = Blood urea nitrogen, CRP = C-reactive protein, eGFRcreatinine = Estimated glomerular filtration rate calculated using the 2009 CKD-EPI creatinine equation, HbA1C = Hemoglobin A1C, HDL-C = High-density lipoprotein cholesterol, LDL-C = Low-density lipoprotein cholesterol, FGF-23 = Fibroblast growth factor-23, CKD = Chronic kidney disease.